Pharmacokinetics of Valganciclovir and Ganciclovir Following Multiple Oral Dosages of Valganciclovir in HIV- and CMV-Seropositive Volunteers

Author： Brown F.  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.37, Iss.2, 1999-08, pp. : 167-176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Population Pharmacokinetics of Ganciclovir Following Administration of Valganciclovir in Paediatric Renal Transplant Patients

By Zhao Wei  

Clinical Pharmacokinetics, Vol. 48, Iss. 5, 2009-05 ,pp. : 321-328

Adis International

Access to resources Recommend Favorite

Exposure to ganciclovir with oral valganciclovir exceeds that of oral ganciclovir

By  

Inpharma, Vol. 1, Iss. 1487, 2005-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Valganciclovir: once-daily alternative to ganciclovir for CMV

By  

Inpharma, Vol. 1, Iss. 1365, 2002-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Valganciclovir

By Curran M.   Noble S.  

Drugs, Vol. 61, Iss. 8, 2001-01 ,pp. : 1145-1150

Adis International

Access to resources Recommend Favorite

Targeted CMV prophylaxis with valganciclovir viable

By  

Inpharma, Vol. 1, Iss. 1289, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite